Browse > Article
http://dx.doi.org/10.7586/jkbns.2020.22.2.71

The Relationship Between Levels of Serum Testosterone and Prostate-specific Antigen in Healthy Men: An Integrative Review  

An, Gyeong-Ju (Department of Nursing, Cheongju University)
Publication Information
Journal of Korean Biological Nursing Science / v.22, no.2, 2020 , pp. 71-80 More about this Journal
Abstract
Purpose: The purpose of this study was to review primary research exploring the correlations between the levels of serum testosterone and the prostate-specific antigen (PSA) in healthy men without prostate diseases. Methods: An integrative review was conducted using the Whittemore & Knafle (2005) framework. The keywords, 'testosterone & prostate-specific antigen', 'testosterone & PSA' and 'healthy men' were used to search peer-reviewed publications in six databases. Among 1,959 searched articles, eleven articles were selected after excluding articles that do not meet inclusion criteria. Literature quality was moderate (Level 3). Results: As a result of this study, it was confirmed through the nine articles that healthy adult men showed no significant correlation between the serum testosterone and the PSA. Conversely, two articles presented that the serum PSA correlate positively with the testosterone. In particular, it is inferred that the effect of the serum testosterone and the PSA secreted into a 24-hour circadian rhythm with different amplitudes and slopes would have had great influence. However, it does not consider the factors affecting the testosterone and the PSA, such as race, liver disease, and BMI, so there is insufficient empirical data to clearly explain the relationship between the testosterone and the PSA. Conclusion: The correlation between the serum testosterone and the PSA in healthy adult men is insignificant in relation to the circadian rhythm of the testosterone and the PSA secretion. It is that a large-scale study including various influencing factors using new biochemical indicators such as pro PSA be conducted in the future.
Keywords
Adult; Prostate-specific antigen; Review; Testosterone;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gurbuz C, Canat L, Atis G, Guner B, Caskurlu T. The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk. Kaohsiung Journal of Medical Sciences. 2012;28:649-653. https://doi.org/10.1016/j.kjms.2012.02.003   DOI
2 Morgentaler A, Rhoden EL. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Urology. 2006. 68(6):1263-1267. https://doi.org/10.1016/j.urology.2006.08.1058   DOI
3 Koo JM, Shim BS. Significance of serum testosterone for prostate-specific antigen (PSA) elevation and prediction of prostate cancer in patients with PSA above 10 ng/ml. Korean Journal of Urology. 2010;51:831-835. https://doi.org/10.4111/kju.2010.51.12.831   DOI
4 Zhang J, Ma M, Nan X. Sheng B. Obesity inversly correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China. Brazillian Journal of Medical and Biological Research. 2016;49(8):e5272. https://doi.org/10.1590/1414-431X20165272   DOI
5 Khera M, Crawford D, Morales A, Salonia A, Morgentaler A. A new era of testosterone and prostate cancer: from physiology to clinical implication. European Urology. 2014;65(1):115-123. https://doi.org/10.1016/j.eururo.2013.08.015   DOI
6 Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A. et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate. 2001;47:52-58. https://doi.org/10.1002/pros.1046   DOI
7 Boyle P, Koechlin A, Bota M, d'Onofrio A, Zaridze DG, Perrin P, et al. Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis. BJU International. 2016;118:731-741. https://doi.org/10.1111/bju.13417   DOI
8 Walsh TJ, Shores MM, Krakauer CA, Forsberg CW, Fox AE, Moore KP, et al. Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels. Plos One 2018;13(6):e0199194. https://doi.org/10.1371/journal.pone.0199194   DOI
9 Morote J, Ramirez C, Gomez E, Planas J, Raventos CX, de Torres IM, et al. The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness. BJU International. 2009;104:486-9. https://doi.org/10.1111/j.1464-410X.2009.08378.x   DOI
10 Albisinni S, De Nunzio C, Tubaro A, Barry WT, Banez LL, Freedland SJ. Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy. Urology. 2012;80(1):162-167. https://doi.org/10.1016/j.urology.2012.01.068   DOI
11 Rastrelli G, Corona G, Vignozzi L, Maseroli E, Silveril A, Monami M et al. Serum PSA as a predictor of testosterone deficiency. Journal of Sex Medicine. 2013;10:2518-2528. https://doi.org/10.1111/jsm.12266   DOI
12 McLaren D, Siemens DR, Izard J, Black A, Morales A. Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome. BJU International. 2008;102(9):1142-1146. https://doi.org/10.1111/j.1464-410X.2008.07811.x.   DOI
13 Albuquerque GAML, Guglielmetti GB, Barbosa JABA, Pontes Jr. J, Fazoli AJC, Cordeiro MD et al. Low serum testosterone is a predictor of high-grade disease in patient with prostate cancer. Revista da Associacao Medica Brasileira. 2017;63(8):704-710. https://doi.org/10.1590/1706-9282.63.08.704   DOI
14 Arunprasad K, Chandramohan. Association between low serum testosterone and prostate cancer behaviour. International Journal of Contemporary Medical Research. 2018;5(8):H1-H4. https://doi.org/10.21276/ijcmr.2018.5.8.3
15 Favilla V, Cimino S, Castelli T, Madonia M, Barbagallo I. Morgia G. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia. BJU International. 2010;106:1700-1703. https://doi.org/10.1111/j.1464-410X.2010.09459.x   DOI
16 Haider A, Zitzmann M, Doros G, Isbam H, Hammerer P, Yassin A. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median follow up of 3 registries. Journal of Urology. 2016;193(1):80-86. https://doi.org/10.1016/j.juro.2014.06.071   DOI
17 Armola RR, Bourgault AM, Halm MA, Board RM, Bucher L, Harrington L et al. Upgrading the American Association of Critical-Care Nurses' evidence-leveling hierarchy. American Journal of Critical Care. 2009;18(5):405-409. https://doi.org/10.4037/ajcc2009170   DOI
18 Cooper CS, MacIndoe JH, Perry PJ, Yates WR, Williams RD, The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men. Journal of Urology. 1996;156:438-441. https://doi.org/10.1097/00005392-199608000-00028   DOI
19 Gerstenbluth RE, Maniam PN, Corty EW, Seftel AD. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement. Journal of Andrology. 2002;23(6):922-926. https://doi.org/10.1002/j.1939-4640.2002.tb02351.x
20 Whittemore R, Knafl K. The integrative review: updated methodology. Journal of Advanced Nursing. 2005;52(5):546-553. https://doi.org/10.1111/j.1365-2648.2005.03621.x   DOI
21 Mermall H, Sothern RB, Kanabrocki EL, Quadri SF, Bremner FW, Nemchausky BA, et al. Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men. Urology. 1995;46(1):45-53. https://doi.org/10.1016/S0090-4295(99)80157-5   DOI
22 Mifsud A, Choon AT, Fang D, Yong EL. Proste-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men. Molecular Human Reproduction. 2001;7(11):1007-1013. https://doi.org/10.1093/molehr/7.11.1007   DOI
23 Sofikerim M, Oruc O, Eskicorapci S, Guliyev F, Ozen H. Correlation of serum androgen and pituitary hormone levels with serum PSA less than 2.5ng/ml. The Scientific World Journal. 2007;7:1128-1133. https://doi.org/10.1100/tsw.2007.177   DOI
24 Mustafa M, Celik M, Horsanali O, Horuz R, Kucukcan A. Relationship between serum PSA and testosterone levels in two different geographic regions of Turkey. Turkish Journal of Urology. 2011; 37: 9-13. https://doi.org/10.5152/tud.2011.002   DOI
25 Elzanaty S, Rezanezhad B, Dohle G. Association between serum testosterone and PSA levels in middle-aged healthy men from the general population. Current Urology. 2016;10:40-44. https://doi.org/10.1159/000447149   DOI
26 Mustafa M, Horuz R, Celik M, Kucukcan A. Is there an association between serum prostate-specific antigen values and serum testosterone levels in healthy men? Korean Journal of Urology. 2014;55:465-468. https://doi.org/10.4111/kju.2014.55.7.465   DOI
27 Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, et al. Circulating total testosterone and PSA concentrations in a nationally representive sample of men without a diagnosis of prostatic cancer. Prostate. 2015;75(11):1167-1176. https://doi.org/10.1002/pros.22998   DOI
28 Mustafa M, Nurigorgel S, Horsanali O, Abu Khadija HA, Marashde OM. PSA and testosterone serum levels in the Middle east: Is there a difference? Journal of Urology and Research. 2015;2(2):1028-1031.
29 Shin YS, You JH, Cha JS, Park JK. The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men. Aging Male. 2016;19(4):209-214. https://doi.org/10.1080/13685538.2016.1229764   DOI
30 Shukla A, Sharda B, Sharma S, Bhardwaj S, Kailash U, Kalani R, et al.. Association between serum testosterone and serum PSA among men with and without partial androgen deficiency. Indian Journal of Clinical Biochemistry. 2020;35(1):127-131. https://doi.org/10.1007/s12291-018-0785-3   DOI
31 Morgentaler A. Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. European Urology. 2009;55(2):310-321. https://doi.org/10.1016/j.eururo.2008.09.024   DOI
32 Partin AW, Catalona WJ, Southwick PC, Subong EN, Gasior GH, Chan DW. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology. 1996;48:55-61. https://doi.org/10.1016/s0090-4295(96)00611-5   DOI
33 Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone -binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young men and elderly men. Journal of Andrology. 1989;10(5):366-371. https://doi.org/10.1002/j.1939-4640.1989.tb00120.x   DOI
34 Shea JL, Wong PY, Chen Y. Free testosterone: clinical utility and important analytical aspects of measurement. Advances in Clinical Chemistry. 2014;63:59-84. https://doi.org/10.1016/b978-0-12-800094-6.00002-9   DOI
35 Choi YD, Kang DR, Nam CM, Kim YS, Cho SY, Kim SJ, et al. Age-specific prostate-specific antigen reference ranges in Korean men. Urology. 2007;70(6):1113-1116. https://doi.org/10.1016/j.urology.2007.07.063   DOI
36 Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. Journal of Urology. 1994;151(6):1571-1574. https://doi.org/10.1016/s0022-5347(17)35304-1   DOI
37 Kilic S, Yalcinkaya S, Guntekin E, Kukul E, Deger N, Sevuk M. Determination of the site of metabolism of total, free, and complexed prostate-specific antigen. Urology. 1998;52(3):470-473. https://doi.org/10.1016/s0090-4295(98)00208-8   DOI
38 Vicentini FC, Botelho LA, Hisano M, Ebaid GX, Lucon M, Lucon AM, et al. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men? Urology. 2009;73(5):1032-1035. https://doi.org/10.1016/j.urology.2009.01.015   DOI
39 Wichendu PN, Odum EP, Amdi C, Aleme BM. Endogenous testosterone to prostate-specific antigen relationship in men without prostatic disease: a 10-year retrospective study. International Surgery Journal. 2018;5(4):1186-1191. https://doi.org/10.18203/2349-2902.isj20181099   DOI
40 National Cancer Information Center. Annual report on the prevalences of cancer [Internet]. Goyang: National Cancer Center; 2020 [cited 2020 Feb 22]. Available from https://www.cancer.go.kr/lay1/S1T639C641/contents.do
41 Akdogan M, Hassoun BS, Guraker A, El-Sahwi K, Jazzar A. Wright H. et al. Prostate-specific antigen levels among cirrhotic patients. International Journal of Biological Markers. 2002;17:161-164. https://doi.org/10.1177/172460080201700303   DOI